Krónikus vesebetegség: vizsgálatok itt: Kína
120 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleQUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 820
- Run by
- Huijie Zhang
See details and how to joinNCT07775846 - 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan, Fuyang, Guangzhou, Haikou, Hefei, Hengyang, Heze, Huaian, Jiaxing, Jilin City, Jinan, Jinhua, Jining, Lanzhou, Linhai, Linyi, Luoyang, Nanchang, Nanning, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taian, Tianjin, Wanzhou, Wuhan, Wuxi, Xi'an, Xianyang, Yantai, Yinchuan, Zhengzhou, Zhongshan, Zhuzhou, Zigong
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleStudy of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 424
- Run by
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07122401 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Beijing, Changchun, Changde, Changzhou, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou, Harbin, Jinan, Jingjiang, Jingzhou, Lishui, Luoyang, Luoyang Shi, Nanchang, Nanjing, Shanghai, Shantou, Suzhou, Wuhan, Xi'an, Xuzhou, Zigong
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - 2. fázisTaking peopleUBT251 Injection Phase II Clinical Study (CKD)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 180
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07134335 - 2. fázisTaking peopleEvaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
- Where
- Beijing, Hangzhou, Nanjing, Shanghai
- Életkor
- 18 év to 75 év
- People
- 80 worldwide
- Run by
- Atom Therapeutics Co., Ltd
See details and how to joinNCT07323095 - 4. fázisTaking peopleA Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
- Where
- Anyang, Baotou, Beijing, Changchun, Changzhou, Chengdu, Dalian, Fuyang, Huizhou, Jinan, Lanzhou, Linhai, Nanjing, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shijiazhuang, Siping, Xining, Yibin, Yichang, Zhenjiang
- Életkor
- 18 év and over
- People
- 300
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07900438 - 2. fázisTaking peopleSafety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
- Where
- Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
- Életkor
- 12 év to 18 év
- People
- 18 worldwide
- Run by
- Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00 - No phaseCsak meghívásosStrategies for Proactive Health in People With Kidney Function Decline
- Where
- Shanghai
- Életkor
- 18 év to 90 év
- People
- 1800
- Run by
- Huashan Hospital
See details and how to joinNCT07245186 - No phaseNot yet taking people in KínaImpact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 380
- Run by
- Shanghai Pudong Hospital
See details and how to joinNCT07888855 - 4. fázisNot yet taking people in KínaStudy on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07877103 - No phaseTaking peopleHAPA-based Intervention in Adults With Metabolic Syndrome and Chronic Kidney Disease
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 160
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06715735 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Beijing, Changchun, Changsha, Guangzhou, Luoyang, Ningbo, Qingdao, Shanghai, Shenzhen, Taiyuan, Ürümqi, Wenzhou, Xian, Yinchuan, Zhengzhou
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 2. fázisNot yet taking people in KínaA Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 315
- Run by
- Zhejiang Doer Biologics Co., Ltd.
See details and how to joinNCT07848880 - 3. fázisTaking peopleA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Dongyang, Ganzhou, Guangzhou, Guiyang, Hebei, Hohhot, Huaian, Jinan, Jining, Jiujiang, Linhai, Nanchang, Nanjing, Nanning, Ningbo, Panjin, Pingxiang, Qingzhou, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Ürümqi, Wuhan, Wuxi, Xiamen, Xuzhou, Yancheng, Yangzhou, Yantai, Yibin, Yinchuan, Zhenjiang, Zhuzhou
- Életkor
- 18 év to 99 év
- People
- 2800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - No phaseCsak meghívásosClinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 868
- Run by
- Capital Medical University
See details and how to joinNCT07645794 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Baotou Shi, Beijeing, Beijing, Chengdu, Dalian, Deyang Shi, Dongguan, Foshan Shi, Guangzhou, Hefei, Jiaxing, Lanzhou, Luoyang Shi, Mianyang, Nanchang, Nanjing, Nanning, Pingxiang, Shanghai, Shanghai Shi, Shenzhen, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuxi, Xiamen, Xianyang, Xinxiang, Yangzhou, Yibin, Zhengzhou, Zhenjiang
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 1. fázisTaking peopleHuman Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
- Where
- Wuhan
- Életkor
- 30 év to 70 év
- People
- 15
- Run by
- Tongji Hospital
See details and how to joinNCT07822152 - No phaseTaking peopleEfficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
- Where
- Guangzhou
- Életkor
- 18 év to 85 év
- People
- 93
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07098351 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Baoding, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chenzhou, Chongqing, Dongguan, Foshan, Ganzhou, Guangzhou, Guiyang, Hefei, Huangshi, Huizhou, Jiangmen, Jining, Linfen, Luoyang, Nanchang, Nanjing, Nanning, Ningbo, Panjin, Pingxiang, Qingzhou, Sacramento, Shanghai, Shantou, Shenzhen, Shijiazhuang, Tianjin, Ürümqi, Wuhan, Wuxi, Xi'an, Xuzhou, Yancheng, Yangzhou, Yantai, Yibin, Zhenjiang, Zhongshan, Zigong, Zunyi
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - 4. fázisTaking peopleUse of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI
- Where
- Dalian
- Életkor
- 18 év to 80 év
- People
- 160
- Run by
- The First Affiliated Hospital of Dalian Medical University
See details and how to joinNCT06946394 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang, Nanjing, Nanyang, Suining Shi, Yibin, Yichang, Zhengzhou
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 2. fázisTaking peopleA Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Where
- Beijing, Chengdu, Nanjing, Shanghai, Zhengzhou
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- R1 Therapeutics
See details and how to joinNCT06712654 - No phaseTaking peopleClinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
- Where
- Baotou, Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hangzhou, Harbin, Qingdao, Shanghai, Shijiazhuang, Tianjin, Wuhan, Wuxi, Xi’an, Yantai, Zhengzhou
- Életkor
- 18 év to 79 év
- People
- 750
- Run by
- Vantive Health LLC
See details and how to joinNCT07781124 - No phaseTaking peopleLineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft
- Where
- Beijing, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Shenzhen, Shijiazhuang, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 326
- Run by
- Longhua Hospital
See details and how to joinNCT07773051